- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02103088
Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners (PROCAN)
PROCAN: Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners: A Randomized Controlled Intervention Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Although the potential negative impact of prostate cancer on sexual and urological function is well documented there is no evidence based and standardized rehabilitation offer available for Danish couples affected by prostate cancer. This study proposal is based on a thorough literature review on PC treatment and late effects and interventions targeting sexual and urological late effects and a qualitative study including interviews with 6 couples affected by PC. The literature review showed that; medical treatment is effective for the treatment of erectile dysfunction, psychosocial intervention may ease sexual problems secondary to operation for prostate cancer and sexual counseling may improve compliance with medical treatment of erectile dysfunction. In regard to treatment of urological dysfunction studies showed that the effect of pelvic floor muscle training is enhanced by follow-up instructions by physiotherapist. Our interview study among patients operated for prostate cancer and their partners indicated a general need and demand for professional help to discuss the changed sexual life. Also studies have shown that health professionals find it difficult to discuss sexual problems with the patients. Medical treatment for erectile dysfunction is prescribed to patients operated for prostate cancer, however the treatment is not offered systematically in all hospitals and furthermore the drugs are sold on the internet.In view of this knowledge we determine that there is a need for studies which include patients systematically offered medical treatment for erectile dysfunction and further is offered sexual counseling and thus focusing on: i) treatment of physical, psychological and social aspects of sexual dysfunction ii) improvement of compliance with the medical treatment for erectile dysfunction and iii) reducing barriers among patients and health professionals for resolving sexual problems secondary to operation for prostate cancer.
The purpose of the PROCAN study is in a randomized design to test the effect of a theory based intervention on sexual and urological dysfunctions secondary to operation for prostate cancer. The PROCAN intervention consists of: i) Digital Video Disc (DVD) instruction in pelvic floor muscle training ii) group instructions in pelvic floor muscle training by physiotherapist including up to three individually follow-up and ii) up to six couple sessions performed by a sexual nurse counselor. The intervention is based on social and cognitive behavioral techniques and techniques derived from sexual therapy and counseling with a psycho-educational approach, in which sexuality is defined as a multidimensional construct involving biological, psychological and social aspects. The intervention is documented and developed in collaboration with urologists, physiotherapists and sexologists. The investigators will enroll patients and partners from the Urological Department Rigshospitalet and randomize 160 couples. Patients and partners will be randomized (1:1) to standard care plus the PROCAN intervention and to standard care (control Group). The investigators hypothesize that the PROCAN intervention will:
- Improve urological and sexual functioning among prostate cancer patients and sexual function and satisfaction among patients and female partners
- Improve the dyadic adjustment and the overall quality of life in prostate cancer patients and their partners
- Reduce the prevalence of depression and anxiety in patients and their partners
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Copenhagen Ø
-
Copenhagen, Copenhagen Ø, Denmark, 2100
- Department of Urology, Rigshospitalet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Patients operated for primary prostate cancer with open or robot-assisted surgery using nerve sparring or non-nerve sparring technique living with a female partner and reported being sexually active before the operation.
Exclusion Criteria:Patients with other cancers (except non-melanoma skin cancer) within 5 years, major psychiatric disorder, abuse of alcohol or drugs, dementia, e.g. Alzheimer's disease and patients, who do not understand or speak Danish. Patients, who reported not being sexually active before the operation and partners who do not understand or speak Danish.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sexual and urological intervention
Standard care and the PROCAN intervention consisting of i) DVD instruction in pelvic floor muscle training ii) group instructions in pelvic floor muscle training by physiotherapist including three individually follow-up and ii) up to six couple sessions performed by a sexual nurse counselor.
|
Sexual and urological intervention consisting of: i) DVD instruction in pelvic floor muscle training ii) group instructions in pelvic floor muscle training by physiotherapist including three individually follow-up and ii) up to six couple sessions performed by a sexual nurse counselor.
|
No Intervention: Control
Standard care consists of:systematic offer of medical treatment for erectile dysfunction, if not contra indicated.
The medical treatment will consist of either daily treatment with Cialis 5 mg or phosphodiesterase type 5 inhibitor on demand before sexual activity.
Alternatively use of alprostadil as either urethral pin or penile injection.
Furthermore standard treatments include preoperative instruction in pelvic floor muscle training, regular outpatient visits and possible referral to rehabilitation in accordance with the rules that apply to the Danish Health legislations.
In case of prolonged incontinence the patients may on request be referred to a private practicing physiotherapist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Erectile function measured by the International Index of Erectile Function (IIEF-15)
Time Frame: Baseline, 8 months and 12 months
|
To investigate the change in erectile function among patients in intervention- and the control group from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 months and 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sexual satisfaction measured by IIEF-15
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in sexual satisfaction among patients from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Female sexual satisfaction measured by The Female Sexual Function Index (FSFI)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in sexual satisfaction among female partners from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Female Sexual Distress measured by the Female Sexual Distress Scale (FSDS)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in female sexual distress from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Urological function measured by The Expanded Prostate Cancer Composite Index (EPIC-26)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in urological function among patients from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Marital function measured by The Dyadic Adjustment Scale (DAS)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in marital function among patients and partners from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Health related quality of life measured by The Short Form Health Survey (SF-36)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in health related quality of life among patients and partners from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Anxiety measured by The Symptom Check List (SCL-92)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in anxiety among patients and partners from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Depression measured by The Major Depression Inventory (MDI)
Time Frame: Baseline, 8 and 12 months
|
To investigate the change in depressive symptoms among patients and partners partners from baseline to 8 and 12 months follow up and the difference in change between intervention - and the control group
|
Baseline, 8 and 12 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Randi V. Karlsen, RN, MEd, Danish Cancer Society
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROCAN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on Sexual and urological intervention
-
The University of Hong KongCompleted
-
Kasr El Aini HospitalUnknownFemales With Overactive Bladder Symptoms, Urgency & Urge Incontinence
-
Ann & Robert H Lurie Children's Hospital of ChicagoHoward Brown Health CenterCompletedSexual Dysfunctions, Psychological | HIV | Substance-related Disorders | Homosexuality, MaleUnited States
-
Royal Holloway UniversityNational Health Service, United KingdomCompletedSexual Dysfunction | Sexual Assault | Sex DisorderUnited Kingdom
-
The Miriam HospitalUniversity of RochesterCompletedSexual BehaviorUnited States
-
Steffanie StrathdeeNational Institute on Drug Abuse (NIDA); San Diego State University; University... and other collaboratorsCompleted
-
Massachusetts General HospitalCompletedSexual DysfunctionUnited States
-
Massachusetts General HospitalUniversity of Miami; Fenway Community HealthCompletedStress Disorders, Post-Traumatic | Sexual Risk Behavior | Childhood Sexual AbuseUnited States
-
The Policy & Research GroupDepartment of Health and Human ServicesCompletedTeen Pregnancy Prevention
-
University of British ColumbiaCompletedLow Female Sexual Arousal | Low Female Sexual DesireCanada